Dr. Schroers-Martin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
875 Blake Wilbur Drive
Palo Alto, CA 94304- Is this information wrong?
Summary
- Dr. Joseph Schroers-Martin is an assistant professor of oncology in the Department of Medicine at Stanford University. After a career in software development, he pursued training first in computational genomics and then in clinical oncology. As a physician scientist, his clinical focus is on post-transplant and Hodgkin lymphomas. His research interests include early lymphomagenesis, virus-associated lymphomas, and the lymphoma tumor microenvironment.
Education & Training
Stanford Health CareFellowship, Hematology and Medical Oncology, 2018 - 2021
Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2015 - 2017
University of Hawaii, John A. Burns School of MedicineClass of 2015
Certifications & Licensure
CA State Medical License 2016 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
- AOA Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Long-term outcome of peripheral T-cell lymphomas: Ten-year follow-up of the International Prospective T-cell Project.Schroers-Martin, J. G., M Civallero, J G Schroers-Martin, S Horwitz, M Manni, Y Stepanishyna, M E Cabrera, J Vose, M Spina, F Hitz, A Nagler, S Montoto, C Chiattone, T...> ;British Journal of Haematology. 2024 Mar 26
- 1 citationsA human lymphoma organoid model for evaluating and targeting the follicular lymphoma tumor immune microenvironment.Jenna M Kastenschmidt, Joseph G Schroers-Martin, Brian J Sworder, Suhas Sureshchandra, Michael S Khodadoust, Chih Long Liu, Mari Olsen, David M Kurtz, Maximilian Diehn...> ;Cell Stem Cell. 2024 Mar 7
- Specificity of immunoglobulin high-throughput sequencing minimal residual disease monitoring in non-Hodgkin lymphomas.Kathuria, K., Frank, M., Miklos, D., Alizadeh, A., Diehn, M., Shukla, N., Schroers-Martin, J., Sworder, B., Alig, S., Coutre, S., Roschewski, M., Khodadoust, M., Kurtz...> ;Blood Advances. 2024 Feb 13
- Join now to see all
Hospital Affiliations
Stanford Health CarePalo Alto, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
